Schedule of segment information |
| | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2025 | | 2024 | | 2025 | | 2024 | | | | (in thousands) | | (in thousands) | Total Revenues | | $ | 101,685 | | $ | 36,841 | | $ | 155,018 | | $ | 66,375 | Less: | | | | | | | | | | | | | Employee related expenses | | | 18,581 | | | 17,080 | | | 38,119 | | | 36,447 | Commercial related expenses | | | 7,273 | | | 7,126 | | | 12,612 | | | 12,260 | Outside clinical trial related expenses | | | 3,232 | | | 2,368 | | | 7,603 | | | 4,880 | Cost of product sales | | | 4,504 | | | 2,807 | | | 8,913 | | | 4,832 | Consultants and third-party services | | | 3,209 | | | 4,033 | | | 6,618 | | | 8,375 | Other segment items | | | 3,783 | | | 2,980 | | | 7,277 | | | 6,100 | Interest expense, net | | | 1,121 | | | 1,477 | | | 2,383 | | | 2,758 | Provision for income taxes | | | 369 | | | — | | | 434 | | | — | Segment income (loss) | | $ | 59,613 | | $ | (1,030) | | $ | 71,059 | | $ | (9,277) |
|